Breakpoints cover image

#68 – IDWeek 2022 Recap: Late Breaking Trials and Pipeline Antibacterials

Breakpoints

00:00

Jepot Is a Novel First in Class Agent

Jepotidison is a novel first in class, a trays, ass and after the last 15, say that five times fast. Think about it as like a flu or quinolone, but different. They're developing it for treatment of uncomplicated urinary tract infections, as well as gonorrhea. The mechanism of action interrupts bacterial DNA replication by inhibiting DNA jires.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app